Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M315Revenue $M0.2Net Margin (%)0Z-Score-5.5
Enterprise Value $M232EPS $-0.9Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book4.710-y EBITDA Growth Rate %0Quick Ratio3.2Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio3.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-83.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)-138.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M109ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with SNTA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNTAJean-Marie Eveillard 2012-06-30 Sold Out -0.0035%$3.68 - $7.82
($4.69)
$ 2.89-62%Sold Out0
SNTAJean-Marie Eveillard 2012-03-31 Buy $4.22 - $5.66
($4.49)
$ 2.89-55%New holding200,000
SNTAMichael Price 2011-06-30 Sold Out -0.1%$4.45 - $6.23
($5.37)
$ 2.89-86%Sold Out0
SNTAMichael Price 2010-06-30 Buy 0.07%$2.67 - $4.79
($3.62)
$ 2.89-25%New holding118,058
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNTA is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SNTA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WILSON ROBERT NDirector 2015-04-06Buy50,000$1.7547.43 view
Gollust Keith RDirector 2015-04-06Buy350,000$1.7547.43 view
Kovner BruceDirector, 10% Owner 2015-04-06Buy6,857,143$1.7547.43 view
Kovner BruceDirector, 10% Owner 2014-09-30Buy300,000$3.08-16.23 view
Kovner BruceDirector, 10% Owner 2014-04-11Buy1,250,000$4.01-35.66 view
Kovner BruceDirector, 10% Owner 2013-11-13Buy5,000,000$3.75-31.2 view
Bahcall Safi RPresident and CEO 2013-11-13Buy20,000$3.75-31.2 view
REARDON WILLIAM SDirector 2013-11-13Buy13,333$3.75-31.2 view
Gollust Keith RDirector 2013-11-13Buy150,000$3.75-31.2 view
Bahcall Safi RPresident and CEO 2013-06-28Buy10,000$5.03-48.71 view

Press Releases about SNTA :

    Quarterly/Annual Reports about SNTA:

    News about SNTA:

    Articles On GuruFocus.com
    Insider Buys: FULL, FMI and SNTA Apr 10 2015 
    Weekly 3-Year Low Highlights: NSR, ELRC, PLPC, SNTA Feb 16 2015 
    5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 09 2015 
    5-year lows: Synta Pharmaceuticals Inc, Rex Energy Corp, Petroquest Energy Inc, and Liquidity Servic Jan 11 2015 
    5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
    Top 4 Insider Buys of Last Week Jun 10 2013 
    Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI Jul 08 2012 
    Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI Jul 07 2012 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 5,000 Shares Mar 15 2011 

    More From Other Websites
    SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 06 2015
    Synta Pharmaceuticals Closes Public Offering of Common Stock Apr 06 2015
    Synta Pharmaceuticals Closes Public Offering of Common Stock Apr 06 2015
    SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Apr 01 2015
    Synta Pharmaceuticals (SNTA) Stock Hits 52-Week Low After Pricing Public Offering Mar 31 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Lorillard, Charter Communications, Synta Pharma Mar 31 2015
    Synta Pharmaceuticals Prices Public Offering of Common Stock Mar 31 2015
    Synta Pharmaceuticals Prices Public Offering of Common Stock Mar 31 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Synta Pharma, Lorillard, BioCryst, Insmed Mar 31 2015
    Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock Mar 30 2015
    Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock Mar 30 2015
    SYNTA PHARMACEUTICALS CORP Financials Mar 19 2015
    Synta's Q4 Loss Narrows Y/Y, Focus on Lung Cancer Drug - Analyst Blog Mar 13 2015
    Synta Pharmaceuticals Corp Earnings Call scheduled for 8:30 am ET today Mar 12 2015
    Synta's (SNTA) Q4 Loss In Line with Expectations - Tale of the Tape Mar 12 2015
    Synta reports 4Q loss Mar 12 2015
    Synta reports 4Q loss Mar 12 2015
    Synta Reports Fourth Quarter and Year-End 2014 Financial Results Mar 12 2015
    Q4 2014 Synta Pharmaceuticals Corp. Earnings Release - Before Market Open Mar 12 2015
    Synta Reports Fourth Quarter and Year-End 2014 Financial Results Mar 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK